GLP-1R agonists effect(s) on vascular smooth muscle cells are equally important to those on endothelial cells with several favorable responses being reported, including enhanced differentiation, attenuated response to reactive oxygen species, reduced vascular remodeling through improved mitochondrial activity and dynamics, and the prevention of aberrant migration [65]
That said, ideal candidates for AIMs Semaglutide Weight Loss Program are typically individuals who: have a BMI of 30 or higher (or a BMI of 27 or higher and at least one weight-related comorbidity, such as insulin resistance)
Patients should experience minimal or no gastrointestinal symptoms at their current dose, with resolution of initial nausea, vomiting, or diarrhea
Improved blood sugar balance and metabolic control
The genetic test does not predict exact medication response or guarantee superior weight loss with tirzepatide or semaglutide
Discussion This study assessed prescribing patterns of GLP-1 RAs in Region Stockholm, Sweden, between 2019 and 2023, with a focus on off-label prescribing
